• NeuromancerOPM
      link
      fedilink
      arrow-up
      1
      arrow-down
      6
      ·
      5 months ago

      No, I think we should limit the cost of drugs based solely on cost to manufacture and distribute, and pay those operational costs

      If we payed for the research. I agree. Otherwise companies will just spend less on research. I don’t mind capping margins unless they don’t enforce the patent.